Hanna M Seidling1,2, Marion Stützle3,4, Torsten Hoppe-Tichy5,4, Benoît Allenet6, Pierrick Bedouch6, Pascal Bonnabry7,8, Jamie J Coleman9, Fernando Fernandez-Llimos10, Christian Lovis11, Maria Jose Rei12, Dominic Störzinger5, Lenka A Taylor5, Sarah K Pontefract9, Patricia M L A van den Bemt13, Heleen van der Sijs13, Walter E Haefeli3,4. 1. Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. hanna.seidling@med.uni-heidelberg.de. 2. Cooperation Unit Clinical Pharmacy, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. hanna.seidling@med.uni-heidelberg.de. 3. Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. 4. Cooperation Unit Clinical Pharmacy, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. 5. Pharmacy Department, University Hospital of Heidelberg, Heidelberg, Germany. 6. Department of Pharmacy, CNRS, TIMC-IMAG UMR 5525, Themas, Grenoble-Alpes University, Grenoble University Hospital, Grenoble, France. 7. Pharmacy, Geneva University Hospitals (HUG), Geneva, Switzerland. 8. School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland. 9. University Hospitals Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, England, UK. 10. Research Institute for Medicines (iMedULisboa), Department of Social Pharmacy, University of Lisboa, Lisbon, Portugal. 11. Division of Medical Information Sciences, Geneva University Hospitals, University of Geneva, Geneva, Switzerland. 12. Pharmacy Department, Hospital da Luz, Lisbon, Portugal. 13. Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Abstract
BACKGROUND: While evidence on implementation of medication safety strategies is increasing, reasons for selecting and relinquishing distinct strategies and details on implementation are typically not shared in published literature. OBJECTIVE: We aimed to collect and structure expert information resulting from implementing medication safety strategies to provide advice for decision-makers. SETTING: Medication safety experts with clinical expertise from thirteen hospitals throughout twelve European and North American countries shared their experience in workshop meetings, on-site-visits and remote structured interviews. METHODS: We performed an expert-based, in-depth assessment of implementation of best-practice strategies to improve drug prescribing and drug administration. MAIN OUTCOME MEASURES: Workflow, variability and recommended medication safety strategies in drug prescribing and drug administration processes. RESULTS: According to the experts, institutions chose strategies that targeted process steps known to be particularly error-prone in the respective setting. Often, the selection was channeled by local constraints such as the e-health equipment and critically modulated by national context factors. In our study, the experts favored electronic prescribing with clinical decision support and medication reconciliation as most promising interventions. They agreed that self-assessment and introduction of medication safety boards were crucial to satisfy the setting-specific differences and foster successful implementation. CONCLUSION: While general evidence for implementation of strategies to improve medication safety exists, successful selection and adaptation of a distinct strategy requires a thorough knowledge of the institute-specific constraints and an ongoing monitoring and adjustment of the implemented measures.
BACKGROUND: While evidence on implementation of medication safety strategies is increasing, reasons for selecting and relinquishing distinct strategies and details on implementation are typically not shared in published literature. OBJECTIVE: We aimed to collect and structure expert information resulting from implementing medication safety strategies to provide advice for decision-makers. SETTING: Medication safety experts with clinical expertise from thirteen hospitals throughout twelve European and North American countries shared their experience in workshop meetings, on-site-visits and remote structured interviews. METHODS: We performed an expert-based, in-depth assessment of implementation of best-practice strategies to improve drug prescribing and drug administration. MAIN OUTCOME MEASURES: Workflow, variability and recommended medication safety strategies in drug prescribing and drug administration processes. RESULTS: According to the experts, institutions chose strategies that targeted process steps known to be particularly error-prone in the respective setting. Often, the selection was channeled by local constraints such as the e-health equipment and critically modulated by national context factors. In our study, the experts favored electronic prescribing with clinical decision support and medication reconciliation as most promising interventions. They agreed that self-assessment and introduction of medication safety boards were crucial to satisfy the setting-specific differences and foster successful implementation. CONCLUSION: While general evidence for implementation of strategies to improve medication safety exists, successful selection and adaptation of a distinct strategy requires a thorough knowledge of the institute-specific constraints and an ongoing monitoring and adjustment of the implemented measures.
Authors: Nancy L Greengold; Rita Shane; Philip Schneider; Elizabeth Flynn; Janet Elashoff; Cheryl L Hoying; Kenneth Barker; Linda Burnes Bolton Journal: Arch Intern Med Date: 2003-10-27
Authors: Yong Y Han; Joseph A Carcillo; Shekhar T Venkataraman; Robert S B Clark; R Scott Watson; Trung C Nguyen; Hülya Bayir; Richard A Orr Journal: Pediatrics Date: 2005-12 Impact factor: 7.124
Authors: Paul G Shekelle; Peter J Pronovost; Robert M Wachter; Stephanie L Taylor; Sydney M Dy; Robbie Foy; Susanne Hempel; Kathryn M McDonald; John Ovretveit; Lisa V Rubenstein; Alyce S Adams; Peter B Angood; David W Bates; Leonard Bickman; Pascale Carayon; Liam Donaldson; Naihua Duan; Donna O Farley; Trisha Greenhalgh; John Haughom; Eileen T Lake; Richard Lilford; Kathleen N Lohr; Gregg S Meyer; Marlene R Miller; Duncan V Neuhauser; Gery Ryan; Sanjay Saint; Kaveh G Shojania; Stephen M Shortell; David P Stevens; Kieran Walshe Journal: Ann Intern Med Date: 2011-05-17 Impact factor: 25.391
Authors: L L Leape; D W Bates; D J Cullen; J Cooper; H J Demonaco; T Gallivan; R Hallisey; J Ives; N Laird; G Laffel Journal: JAMA Date: 1995-07-05 Impact factor: 56.272
Authors: Sabi Redwood; Nothando B Ngwenya; James Hodson; Robin E Ferner; Jamie J Coleman Journal: BMC Med Inform Decis Mak Date: 2013-06-04 Impact factor: 2.796
Authors: Deonni P Stolldorf; Sheila H Ridner; Timothy J Vogus; Christianne L Roumie; Jeffrey L Schnipper; Mary S Dietrich; David G Schlundt; Sunil Kripalani Journal: Implement Sci Commun Date: 2021-06-10